Best The Pmc 2025 Podcasts (2025)

1
Blood Type A Identified as Potential Breast Cancer Risk Factor 3:19

3d ago3:19

3:19

BUFFALO, NY - May 14, 2025 – A new #review paper was #published in Volume 16 of Oncotarget on May 9, 2025, titled “Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis."A comprehensive study, led by first authors Rahaf Alchazal from Yarmouk University and Khaled J. Zaitoun from Johns …

1
What's really going on in the rental market? With Drake Farmer, COO of Renti 40:12

3d ago40:12

40:12

🎙️ Welcome to another unmissable episode of The Alternative Property Management Show — powered by the legends at Renti! This week, we’re turning up the heat with none other than Drake Farmer, COO of Renti and one of the sharpest minds in proptech. Drake joins the boys to unpack what’s really going on in a rental market that’s starting to shift — ye…

1
Drake Farmer, COO of Renti. What's really going on in the rental market? 40:12

4d ago40:12

40:12

🎙️ Welcome to another unmissable episode of The Alternative Property Management Show — powered by the legends at Renti! This week, we’re turning up the heat with none other than Drake Farmer, COO of Renti and one of the sharpest minds in proptech. Drake joins the boys to unpack what’s really going on in a rental market that’s starting to shift — ye…

1
Part 6: Think Small

6d ago

—

Part 6: Think SmallBy Shane Anderson

1
METTL3 Drives Oral Cancer by Blocking Tumor-Suppressing Gene 3:37

8d ago3:37

3:37

BUFFALO, NY - May 9, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on May 8, 2025, titled “METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p/SMAD4 axis."In this study, researchers Jayasree Peroth Jayaprakash, Pragati Karemore, and Piyush Khandelia from the Birla Institute of Technology and Science, India…

1
What happens when MBIE audit your business? 39:38

9d ago39:38

39:38

Welcome to the second episode of The Alternative Property Management Show, brought to you by The PMC and proudly powered by Renti 🎤🎧. In this episode, our own Harrison Vaughan from Tommy’s Property Management shares his experience and insights from his recent MBIE audit—what went well, what surprised him, and what others can learn. We also dive int…

1
Panitumumab & Low-Dose Capecitabine: Promising Maintenance Therapy for Metastatic Colorectal Cancer 6:48

9d ago6:48

6:48

A recent #study from Assiut University Hospital in Egypt, published in #Oncotarget, presents a promising strategy for patients with metastatic #colorectalcancer (mCRC). The #research introduces a gentler yet effective maintenance therapy that may extend survival, enhance quality of life, and offer a more accessible treatment option for mCRC patient…

1
Oncotarget Participation at SSP 2025 Annual Meeting 1:37

12d ago1:37

1:37

BUFFALO, NY - May 5, 2025 – Oncotarget, #published by Impact Journals, is proud to #announce its presence as an #exhibitor at the 47th Annual Meeting of the Society for Scholarly Publishing (SSP), taking place May 28–30, 2025, at the Hilton Baltimore in Maryland. Impact Journals publishes scholarly journals in the biomedical sciences, with a focus …

1
AU Baccalaureate 2025

14d ago

—

AU Baccalaureate 2025By Ivan Williams

1
A changing landscape in the rental market that now favours the tenant 35:15

16d ago35:15

35:15

🎙️ Welcome to the first episode of the latest series of The Alternative Property Management Show, proudly brought to you by The PMC and Renti. We dive into the real issues shaping the property management industry with zero spin, plenty of laughs, and a healthy dose of footy talk on the side. In this opening episode, your hosts David Faulkner, Will …

1
Early Immune Evasion Found in HPV-Related Pre-Cancer Lesions of the Anogenital Region 4:28

19d ago4:28

4:28

BUFFALO, NY - April 28, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on April 24, 2025, titled “PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region."Researchers Humberto Carvalho Carneiro, Rodrigo de Andrade Natal, José Vassallo and Fernando Augusto Soares from the Instituto D’…

1
Part 5: A Taste of Heaven

21d ago

—

Part 5: A Taste of HeavenBy Shane Anderson

1
New Insights into p53: A Powerful Gene’s Role in Cancer Therapy 7:01

24d ago7:01

7:01

A new study from the Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, published in Oncotarget, reveals that the gene p53, long known as the “guardian of the genome,” may be even more powerful than previously thought. By studying it in non-cancerous human cells, researchers discovered how p53 stops risky cel…

1
Part 4: One Final Revolution

28d ago

—

Part 4: One Final RevolutionBy Shane Anderson

1
Gene Variant Linked to Benign Prostate Hyperplasia Risk in Lebanese Men 4:41

1M ago4:41

4:41

BUFFALO, NY - April 15, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on April 4, 2025, titled “Association between two single nucleotide polymorphisms of the Prostaglandin-Endoperoxide Synthase 1 and 2 genes and cell proliferative prostatic diseases in Lebanon."The team of researchers led by first author Brock J. Sheehan an…

1
Part 3: Ministers Rule

1M ago

—

Part 3: Ministers RuleBy Shane Anderson

1
Protein GSK3β Offers New Angle on Overcoming Melanoma Drug Resistance 3:59

1M ago3:59

3:59

BUFFALO, NY - April 11, 2025 – A new research perspective was published in Oncotarget, Volume 16, on April 4, 2025, titled “GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells."In this work, first author Diana Crisan and corresponding author Abhijit Basu from the University Hospital Ulm led a team that pre…

1
Targeting SETDB1: A New Strategy for Treating Osteosarcoma 6:12

1M ago6:12

6:12

Despite decades of research, treatment for osteosarcoma has remained largely unchanged, especially for patients whose cancer spreads or returns. However, a growing body of evidence, summarized in the review “SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types,” published in Oncotarget, highlights …

1
Pentecost 2025

1M ago

—

Pentecost 2025By Mark Finley

1
AI That Measures Its Own Uncertainty Could Improve Liver Cancer Detection 3:37

1M ago3:37

3:37

BUFFALO, NY - April 8, 2025 – A new #editorial was #published in Oncotarget, Volume 16, on April 4, 2025, titled “Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques."Dr. Yashbir Singh from Mayo Clinic and his colleagues discussed how artificial intelligence (AI) can improve liver imaging b…

1
Triple Therapy Slows Glioblastoma Growth and Extends Survival in Preclinical Study 3:46

1M ago3:46

3:46

BUFFALO, NY - April 4, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on March 27, 2025, titled “Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT."Researchers from Brown University, led by first author Lanlan …

1
More Than MORE+

2M ago

—

More Than MORE+By Shane Anderson

1
Single Protein Mimics Retinoic Acid Therapy to Help Leukemia Cells Mature 3:51

2M ago3:51

3:51

BUFFALO, NY - March 31, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on March 21, 2025, titled “FGR Src family kinase causes signaling and phenotypic shift mimicking retinoic acid-induced differentiation of leukemic cells."A research team led by first author Noor Kazim and corresponding author Andrew Yen from Cornell Univer…

1
NSD2 Gene Drives Cancer Cell Identity in Multiple Myeloma 4:39

2M ago4:39

4:39

BUFFALO, NY - April 2, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma."Researchers Andrea Gunnell, Scott T. Kimber, Richard Houlston, and Martin Kaiser from The Institute of Cancer Research, London, studied how…

1
When the Cure Becomes the Cause: A Rare Case of Cancer from Donor Cells 4:57

2M ago4:57

4:57

A young woman beat leukemia; however, nine years later, she faced a different blood cancer. This rare twist, reported recently in Oncotarget, reveals an unexpected risk of bone marrow transplants and opens new questions about long-term outcomes and donor screening.Bone Marrow TransplantBone marrow transplants, also known as hematopoietic stem cell …

1
Why Some Breast Cancer Treatments Stop Working 4:11

2M ago4:11

4:11

BUFFALO, NY - March 25, 2025 – A new #review was #published in Oncotarget, Volume 16, on March 13, 2025, titled “Signaling pathway dysregulation in breast cancer."In this review article, Dinara Ryspayeva and colleagues from Brown University provide a detailed look at how breast cancer cells change the way they communicate and grow—helping tumors su…

1
A Loaf, a Cup, and a Guarantee

2M ago

—

A Loaf, a Cup, and a GuaranteeBy Shane Anderson

1
Clear Scans Can Be Misleading: Residual Cancer Linked to Worse Outcomes 3:49

2M ago3:49

3:49

BUFFALO, NY - March 21, 2025 – A new #editorial was #published in Oncotarget, Volume 16, on March 13, 2025, titled “No disease left behind."In this editorial, Dr. Muzamil Arshad from the University of Chicago Medical Center and colleagues highlight a growing concern in cancer care: radiotherapy may leave behind microscopic cancer even when scan ima…

1
More of MORE+

2M ago

—

More of MORE+By Shane Anderson

1
WIN Consortium Leading the Future of Precision Cancer Medicine 4:46

2M ago4:46

4:46

BUFFALO, NY - March 18, 2025 – A new precision oncology paper was #published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients."Led by Oncotarget Editor-in-Chief Dr. Wafik S. El-Deiry and a global team of researc…

1
Oncotarget to Participate at the AACR Annual Meeting 2025 2:09

2M ago2:09

2:09

BUFFALO, NY - March 17, 2025 – Impact Journals (Oncotarget’s publisher), is pleased to announce its participation as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2025. The meeting is scheduled for April 25-30, 2025, at the McCormick Place Convention Center in Chicago, Illinois.The 2025 AACR Annual Meeting's cen…

1
A Rare Genetic Shift That Helped Lung Cancer Evade Treatment 6:06

2M ago6:06

6:06

What if a cancer treatment worked—until it suddenly didn’t? A new case report, “Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report,” published in Oncotarget, reveals how a non-small cell lung cancer (NSCLC) patient developed drug resistance thr…

1
Rethinking Breast Cancer Screening: New Insights on Overdiagnosis 4:45

2M ago4:45

4:45

BUFFALO, NY – March 12, 2025 – A new #editorial was #published in Oncotarget, Volume 16, on March 10, 2025, titled “COMETgazing – interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE.”Dr. Mangesh A. Thorat, affiliated with Queen Mary University of London, Homerton University Hospital, and King’s…

1
Be An Elijah

2M ago

—

Be An ElijahBy Don MacLafferty

1
How Environmental Exposures Affect Genes and Increase Cancer Risk 4:11

2M ago4:11

4:11

BUFFALO, NY - March 11, 2025 – A new #editorial was #published in Oncotarget, Volume 16, on March 10, 2025, titled “EXPOSOMES and GENES: The duo influencing CANCER initiation and progression."In this editorial, Drs. Uzma Saqib, Katherine E. Ricks, Alexander G. Obukhov, and Krishnan Hajela from Devi Ahilya Vishwavidyalaya (DAVV) in Indore, India, di…

1
Engineered TIMP Molecules Show Potential to Slow Glioblastoma Brain Cancer Spread 4:21

3M ago4:21

4:21

BUFFALO, NY - March 3, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on February 28, 2025, titled “Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells."Elham Taheri and Maryam Raeeszadeh-Sarmazdeh from the University of Nevada, Reno, explored a new approach to slow…

1
MORE+

3M ago

—

MORE+By Shane Anderson

1
How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success 5:48

3M ago5:48

5:48

Imagine if a single blood test could tell clinicians in real time how successful a cancer surgery has been. A recent study from the University of Brasília, published in Oncotarget, suggests that such an approach might soon be possible. By tracking changes in cell-free DNA (cfDNA) levels before, during, and after colorectal cancer (CRC) surgery, res…

1
Power of Weakness

3M ago

—

Power of WeaknessBy J-Fiah Reeves

1
Researchers Identify New p53 Targets to Combat Cancer Growth 5:39

3M ago5:39

5:39

BUFFALO, NY - February 24, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on February 18, 2025, titled “Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells."Researchers Jessica J. Miciak, Lucy Petrova, Rhythm Sajwan, Aditya Pandya, Mikayla Deckard, Andrew J. Munoz, and Fred Bunz fro…

1
Innovative Biomaterial Accelerates Healing of Chemotherapy-Induced Oral Ulcers in Animal Model 4:13

3M ago4:13

4:13

BUFFALO, NY - February 25, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on February 18, 2025, titled “Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters’ model: A regenerative approach using electrospun poly(Lactic-co-Glycolic Acid) membrane."Researchers from the Federal University of Rio de Ja…

1
Panitumumab with Low-Dose Capecitabine as a Maintenance Regimen: A Viable Option? 4:23

3M ago4:23

4:23

BUFFALO, NY - February 18, 2025 – A new #researchpaper was #published in Oncotarget, Volume 16, on February 12, 2025, titled “Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen."In this study, researchers Doaa A. Gamal, Aiat Morsy, and Mervat Omar from Assiut University Hospital, evaluated a new maintenance trea…

1
SETDB1 Amplification Identified as a Potential Target for New Osteosarcoma Treatment 4:19

3M ago4:19

4:19

BUFFALO, NY – February 14, 2025 – A new #review was #published in Oncotarget, Volume 16, on February 12, 2025, titled “SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types.”Authors Elodie Verdier, Nathalie Gaspar, Maria Eugenia Marques Da Costa, and Antonin Marchais from the Gustave Roussy Cancer C…

1
HER2-Low Breast Cancer: A New Understanding 8:01

3M ago8:01

8:01

For years, breast cancer has been classified as either HER2-positive or HER2-negative, determining whether a patient could receive HER2-targeted therapies like trastuzumab (Herceptin). However, a growing body of research suggests a middle category—HER2-low breast cancer—which has led to important changes in how clinicians approach treatment.A recen…

1
Rare Case of Donor Cell-Derived Blood Cancer Discovered Nine Years After Stem Cell Transplant 4:35

3M ago4:35

4:35

BUFFALO, NY - February 10, 2025 – A new #casereport was #published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation."In this case report, Aleksandra Mroczkowska-Bękarciak and Tomasz Wróbel from Wroclaw Medical University desc…

1
New Genetic Mutation Linked to Drug Resistance in Non-Small Cell Lung Cancer Patient 3:47

3M ago3:47

3:47

BUFFALO, NY - February 6, 2025 – A new #casereport was #published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report."In this case report, Jenny L. Wu from Vanderbilt University School of …

1
Part 2: The Great Omission

3M ago

—

Part 2: The Great OmissionBy Shane Anderson

1
A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1 6:43

4M ago6:43

6:43

An unexpected link between KLRG1 and PD-1, two key immune system proteins, was revealed in a study recently published in Oncotarget. This discovery could help explain why some cancer immunotherapy treatments are less effective for certain patients and lead to new therapeutic strategies.How the Immune System Fights CancerThe immune system is a power…

1
Tracking cfDNA Release Dynamics During Colorectal Cancer Surgery 3:54

4M ago3:54

3:54

BUFFALO, NY - January 27, 2025 – A new #research paper was #published in Oncotarget's Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery."Researchers from the University of Brasília investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after colorectal cancer …

1
HER2-Low Breast Cancer: Genomic Insights and Evolving Treatment Paradigms 4:03

4M ago4:03

4:03

BUFFALO, NY - January 22, 2025 – A new #review was #published in Oncotarget's Volume 16 on January 20, 2025, titled “Evolving concepts in HER2-low breast cancer: Genomic insights,definitions, and treatment paradigms."Researchers Whitney L. Hensing, Emily L. Podany, James J. Sears, Shaili Tapiavala, and Andrew A. Davis from the University of Missour…

Podcasts Worth a Listen

The Pmc 2025 Podcasts

Podcasts Worth a Listen